An innovative real-time PCR method to measure changes in RNA editing of the serotonin 2C receptor (5-HT2CR) in brain

Maria Fe Lanfranco, Patricia K. Seitz, Michael V. Morabito, Ronald B. Emeson, Elaine Sanders-Bush, Kathryn Cunningham

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The serotonin 2C receptor (5-HT2CR) plays a significant role in psychiatric disorders (e.g., depression) and is a target for pharmacotherapy. The 5-HT2CR is widely expressed in brain and spinal cord and is the only G-protein coupled receptor currently known to undergo mRNA editing, a post-transcriptional modification that results in translation of distinct, though closely related, protein isoforms. The 5-HT2CR RNA can be edited at five sites to alter up to three amino acids resulting in modulation of receptor:G-protein coupling and constitutive activity. To rapidly quantify changes ex vivo in individual 5-HT2CR isoform levels in response to treatment, we adapted quantitative (real-time) reverse transcription polymerase chain reaction (qRT-PCR) utilizing TaqMan® probes modified with a minor groove binder (MGB). Probes were developed for four 5-HT2CR RNA isoforms and their sensitivity and specificity were validated systematically using standard templates. Relative expression of the four isoforms was measured in cDNAs from whole brain extracted from 129S6 and C57BL/6J mice. Rank order derived from this qRT-PCR analysis matched that derived from DNA sequencing. In mutant mice solely expressing either non-edited or fully edited 5-HT2CR transcripts, only expected transcripts were detected. These data suggest this qRT-PCR method is a precise and rapid means to detect closely related mRNA sequences ex vivo without the necessity of characterizing the entire 5-HT2CR profile. Implementation of this technique will expand and expedite studies of specific brain 5-HT2CR mRNA isoforms in response to pharmacological, behavioral and genetic manipulation, particularly in ex vivo studies which require rapid collection of data on large numbers of samples.

Original languageEnglish (US)
Pages (from-to)247-257
Number of pages11
JournalJournal of Neuroscience Methods
Volume179
Issue number2
DOIs
StatePublished - May 15 2009

Fingerprint

Receptor, Serotonin, 5-HT2C
RNA Editing
Real-Time Polymerase Chain Reaction
RNA Isoforms
Polymerase Chain Reaction
Protein Isoforms
Brain
Behavioral Genetics
Messenger RNA
Behavior Control
G-Protein-Coupled Receptors
DNA Sequence Analysis
Inbred C57BL Mouse
GTP-Binding Proteins
Reverse Transcription
Psychiatry
Spinal Cord
Complementary DNA
Pharmacology
RNA

Keywords

  • 5-HTR
  • Minor groove binders
  • Post-transcriptional modification
  • qRT-PCR
  • RNA editing
  • Unlabeled competing probes

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

An innovative real-time PCR method to measure changes in RNA editing of the serotonin 2C receptor (5-HT2CR) in brain. / Lanfranco, Maria Fe; Seitz, Patricia K.; Morabito, Michael V.; Emeson, Ronald B.; Sanders-Bush, Elaine; Cunningham, Kathryn.

In: Journal of Neuroscience Methods, Vol. 179, No. 2, 15.05.2009, p. 247-257.

Research output: Contribution to journalArticle

Lanfranco, Maria Fe ; Seitz, Patricia K. ; Morabito, Michael V. ; Emeson, Ronald B. ; Sanders-Bush, Elaine ; Cunningham, Kathryn. / An innovative real-time PCR method to measure changes in RNA editing of the serotonin 2C receptor (5-HT2CR) in brain. In: Journal of Neuroscience Methods. 2009 ; Vol. 179, No. 2. pp. 247-257.
@article{0a59e72b994e461797a56b815139bf6b,
title = "An innovative real-time PCR method to measure changes in RNA editing of the serotonin 2C receptor (5-HT2CR) in brain",
abstract = "The serotonin 2C receptor (5-HT2CR) plays a significant role in psychiatric disorders (e.g., depression) and is a target for pharmacotherapy. The 5-HT2CR is widely expressed in brain and spinal cord and is the only G-protein coupled receptor currently known to undergo mRNA editing, a post-transcriptional modification that results in translation of distinct, though closely related, protein isoforms. The 5-HT2CR RNA can be edited at five sites to alter up to three amino acids resulting in modulation of receptor:G-protein coupling and constitutive activity. To rapidly quantify changes ex vivo in individual 5-HT2CR isoform levels in response to treatment, we adapted quantitative (real-time) reverse transcription polymerase chain reaction (qRT-PCR) utilizing TaqMan{\circledR} probes modified with a minor groove binder (MGB). Probes were developed for four 5-HT2CR RNA isoforms and their sensitivity and specificity were validated systematically using standard templates. Relative expression of the four isoforms was measured in cDNAs from whole brain extracted from 129S6 and C57BL/6J mice. Rank order derived from this qRT-PCR analysis matched that derived from DNA sequencing. In mutant mice solely expressing either non-edited or fully edited 5-HT2CR transcripts, only expected transcripts were detected. These data suggest this qRT-PCR method is a precise and rapid means to detect closely related mRNA sequences ex vivo without the necessity of characterizing the entire 5-HT2CR profile. Implementation of this technique will expand and expedite studies of specific brain 5-HT2CR mRNA isoforms in response to pharmacological, behavioral and genetic manipulation, particularly in ex vivo studies which require rapid collection of data on large numbers of samples.",
keywords = "5-HTR, Minor groove binders, Post-transcriptional modification, qRT-PCR, RNA editing, Unlabeled competing probes",
author = "Lanfranco, {Maria Fe} and Seitz, {Patricia K.} and Morabito, {Michael V.} and Emeson, {Ronald B.} and Elaine Sanders-Bush and Kathryn Cunningham",
year = "2009",
month = "5",
day = "15",
doi = "10.1016/j.jneumeth.2009.01.027",
language = "English (US)",
volume = "179",
pages = "247--257",
journal = "Journal of Neuroscience Methods",
issn = "0165-0270",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - An innovative real-time PCR method to measure changes in RNA editing of the serotonin 2C receptor (5-HT2CR) in brain

AU - Lanfranco, Maria Fe

AU - Seitz, Patricia K.

AU - Morabito, Michael V.

AU - Emeson, Ronald B.

AU - Sanders-Bush, Elaine

AU - Cunningham, Kathryn

PY - 2009/5/15

Y1 - 2009/5/15

N2 - The serotonin 2C receptor (5-HT2CR) plays a significant role in psychiatric disorders (e.g., depression) and is a target for pharmacotherapy. The 5-HT2CR is widely expressed in brain and spinal cord and is the only G-protein coupled receptor currently known to undergo mRNA editing, a post-transcriptional modification that results in translation of distinct, though closely related, protein isoforms. The 5-HT2CR RNA can be edited at five sites to alter up to three amino acids resulting in modulation of receptor:G-protein coupling and constitutive activity. To rapidly quantify changes ex vivo in individual 5-HT2CR isoform levels in response to treatment, we adapted quantitative (real-time) reverse transcription polymerase chain reaction (qRT-PCR) utilizing TaqMan® probes modified with a minor groove binder (MGB). Probes were developed for four 5-HT2CR RNA isoforms and their sensitivity and specificity were validated systematically using standard templates. Relative expression of the four isoforms was measured in cDNAs from whole brain extracted from 129S6 and C57BL/6J mice. Rank order derived from this qRT-PCR analysis matched that derived from DNA sequencing. In mutant mice solely expressing either non-edited or fully edited 5-HT2CR transcripts, only expected transcripts were detected. These data suggest this qRT-PCR method is a precise and rapid means to detect closely related mRNA sequences ex vivo without the necessity of characterizing the entire 5-HT2CR profile. Implementation of this technique will expand and expedite studies of specific brain 5-HT2CR mRNA isoforms in response to pharmacological, behavioral and genetic manipulation, particularly in ex vivo studies which require rapid collection of data on large numbers of samples.

AB - The serotonin 2C receptor (5-HT2CR) plays a significant role in psychiatric disorders (e.g., depression) and is a target for pharmacotherapy. The 5-HT2CR is widely expressed in brain and spinal cord and is the only G-protein coupled receptor currently known to undergo mRNA editing, a post-transcriptional modification that results in translation of distinct, though closely related, protein isoforms. The 5-HT2CR RNA can be edited at five sites to alter up to three amino acids resulting in modulation of receptor:G-protein coupling and constitutive activity. To rapidly quantify changes ex vivo in individual 5-HT2CR isoform levels in response to treatment, we adapted quantitative (real-time) reverse transcription polymerase chain reaction (qRT-PCR) utilizing TaqMan® probes modified with a minor groove binder (MGB). Probes were developed for four 5-HT2CR RNA isoforms and their sensitivity and specificity were validated systematically using standard templates. Relative expression of the four isoforms was measured in cDNAs from whole brain extracted from 129S6 and C57BL/6J mice. Rank order derived from this qRT-PCR analysis matched that derived from DNA sequencing. In mutant mice solely expressing either non-edited or fully edited 5-HT2CR transcripts, only expected transcripts were detected. These data suggest this qRT-PCR method is a precise and rapid means to detect closely related mRNA sequences ex vivo without the necessity of characterizing the entire 5-HT2CR profile. Implementation of this technique will expand and expedite studies of specific brain 5-HT2CR mRNA isoforms in response to pharmacological, behavioral and genetic manipulation, particularly in ex vivo studies which require rapid collection of data on large numbers of samples.

KW - 5-HTR

KW - Minor groove binders

KW - Post-transcriptional modification

KW - qRT-PCR

KW - RNA editing

KW - Unlabeled competing probes

UR - http://www.scopus.com/inward/record.url?scp=63049122383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63049122383&partnerID=8YFLogxK

U2 - 10.1016/j.jneumeth.2009.01.027

DO - 10.1016/j.jneumeth.2009.01.027

M3 - Article

VL - 179

SP - 247

EP - 257

JO - Journal of Neuroscience Methods

JF - Journal of Neuroscience Methods

SN - 0165-0270

IS - 2

ER -